Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04567108
Other study ID # 2020p002494
Secondary ID 1R01DK125803-01
Status Recruiting
Phase N/A
First received
Last updated
Start date April 22, 2021
Est. completion date June 1, 2025

Study information

Verified date September 2023
Source Brigham and Women's Hospital
Contact Deirdre K Tobias, ScD
Phone 617-732-5500
Email dtobias@bwh.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sugar-sweetened beverages (SSBs) contribute an alarming ~7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Therefore, the investigators will conduct a 4-arm randomized diet intervention trial to test the effects of substituting SSBs with calorie-free alternatives on body weight and health, among habitual SSB consumers with overweight/obesity.


Description:

The SUBstituting with Preferred OPtions (SUB-POP) trial, is a parallel-arm randomized controlled trial (RCT) to test the effects of substituting SSBs with non-caloric options on body weight and markers of type 2 diabetes and cardiometabolic health. Eligible adult participants will be randomized to 1 of 4 beverage groups and receive at-home monthly deliveries of beverages for 6 months. In-person clinic visits will be conducted at baseline, 6, and 12 months. After the 6 months of assigned beverage substitution and delivery, all participants will be instructed to substitute SSBs with water only for a final 6-month observational period. In-person clinic visits will collect technician-measured anthropometrics, blood pressure, biospecimen samples (blood, urine, stool [subset]), and assess physical activity, diet, beverage frequency, and taste preference. The SUB-POP app-based assessments and online diet recall will ascertain daily beverage intake, while diet (via 3 24-hour recalls), physical activity, and overall beverage frequency will be collected every 1-3 months. A subset will receive at-home digital scales to transmit daily body weight for energy balance and caloric compensation modeling. SUB-POP is a novel RCT that will enroll adult regular SSB consumers with overweight or obesity to evaluate the effectiveness of substituting SSBs with non-caloric options in a real-world, un-blinded setting. The trial will leverage social media recruitment methods, achieve ≥30% non-White participants, implement innovative intervention delivery, adherence, and data collection tools, and partition the artificially-sweetened beverage (ASB) substitution intervention to the two most common artificial sweetener types (aspartame, sucralose) to explore potential heterogeneity. Whether ASBs, which are largely free of calories and sugar, provide a healthful interim strategy to transition to water among habitual SSB consumers is unknown. Thus, by addressing this large gap in the understanding of how to address a highly prevalent and concerning dietary exposure, the investigators will inform dietary guidelines and clinical recommendations for the prevention of obesity, type 2 diabetes, and cardiometabolic disease risks. The primary outcomes are change in body weight from baseline to 6 months between the 3 beverage substitution groups (aspartame ASBs, sucralose ASBs, and water) vs. the maintain SSBs control group, adjusting for multiple comparisons. The investigators and staff will be blinded to group assignment at outcome assessments. Intention-to-treat analysis will be used. After 9/1/2023 the 2 ASB intervention groups (sucralose, aspartame) are combined into a single ASB intervention group; participants randomized on or after 9/1/2023 will be randomized to 1 of 3 beverage groups: maintain SSBs (months 0-6; then switch to water months 6-12); switch to ASBs (months 0-6; then switch to water months 6-12); switch to water (months 0-12). The primary outcomes are change in body weight from baseline to 6 months between the 2 beverage substitution groups (ASBs [all ASB intervention groups combined] and water) vs. the maintain SSBs control group, adjusting for multiple comparisons.


Recruitment information / eligibility

Status Recruiting
Enrollment 460
Est. completion date June 1, 2025
Est. primary completion date June 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 69 Years
Eligibility Inclusion Criteria: 1. Adults aged 20-69 years 2. Consume =1 serving/day (12 oz.) of SSBs (SSBs include soda, fruit drinks, energy drinks, sports drinks, and sweetened waters, sweetened with high fructose corn syrup, sucrose, or fruit juices. SSBs do not include 100% fruit juice, sweetened teas, or flavored milk.) 3. BMI 25.0 to 45.0 kg/m2 4. Access to a smartphone and willingness and ability to download study app 5. Willing to consume beverages consistent with any of the 4 possible group assignments for 6 months Exclusion Criteria: 1. Physician diagnosis of T2D or fasting glucose =126 mg/dL at in-person screening visit 2. Intention to move away from greater Boston area within 1 year from randomization 3. Major medical illness (known cardiovascular disease, cancer, kidney disease, cirrhosis, etc.) 4. Phenylketonuria (PKU) 5. Medication that may affect weight or other study endpoints 6. Another family or household member participating in the study 7. Pregnant in the past 12 months, currently breastfeeding, or planning to become pregnant during the study period

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Maintain usual SSBs
Instruction/guidelines to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)
Substitute to non-SSBs
Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)
Study app
Engage with a motivational mobile app to track beverage intake and complete study data collection
Beverage delivery
Select from approved beverages for a monthly at-home delivery (months 0-6)

Locations

Country Name City State
United States Brigham and Women's Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Brigham and Women's Hospital National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Waist Circumference Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Sussex Sweet Taste Preference Score Change (0 to 100 where higher score indicates greater liking of sweet taste) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Total Beverage Intake Change (oz/d) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other SSB Beverage Intake Change (oz/d) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other ASB Beverage Intake Change (oz/d) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Water Intake Change (oz/d) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other HOMA-IR Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Fasting Blood Insulin Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Fasting Plasma Glucose Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other HbA1c Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Triglycerides Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other TG/HDL Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other HDL-C Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other LDL-C Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Blood Pressure (Systolic and Diastolic) Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other hsCRP Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Interleukin-6 Change Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Alternative Healthy Eating Index 2015 Diet Score Change (Scale 0 to 100 with higher score indicating greater adherence to the dietary pattern) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Self-Reported Added Sugar Change (g/d from 24 hour diet recall) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Self Reported Added Sugar Change (%kcal/d from 24 hour diet recall) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Sweets/Desserts Change (serv/d from 24 hour diet recall) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Total Physical Activity Change (MET-hrs/wk) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Other Energy Compensation (kcal/d) Estimated from Repeated Body Weights (Assessed via At-Home Scale) vs. Repeated Energy Intake (Derived from Repeated Self-Reported 24-Hour Diet Recalls) Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6, Month 12
Primary Weight Change at 6 months Change in total body weight calculated as the month 6 weight minus the baseline weight Baseline, Month 6
Secondary Waist Circumference Change Calculated as month 6 minus baseline value Baseline, Month 6
Secondary Sussex Sweet Taste Preference Score Change (0 to 100 where higher score indicates greater liking of sweet taste) Calculated as month 6 minus baseline value Baseline, Month 6
Secondary Beverage Intake Change (oz/d) Calculated as month 6 minus baseline value Baseline, Month 6
Secondary Fasting Plasma Glucose Change Calculated as month 6 minus baseline value Baseline, Month 6
Secondary Fasting Blood Insulin Change Calculated as month 6 minus baseline value Baseline, Month 6
Secondary HOMA-IR Change Calculated as month 6 minus baseline value Baseline, Month 6
Secondary HbA1c Change Calculated as month 6 minus baseline value Baseline, Month 6
Secondary TG/HDL Ratio Change Calculated as month 6 minus baseline value Baseline, Month 6
Secondary Weight Change Sustainability Calculated as month 6 minus baseline value, month 12 minus month 6 value Baseline, Month 6
See also
  Status Clinical Trial Phase
Completed NCT04085861 - Mental Health in Dancers; an Intervention Study N/A
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Not yet recruiting NCT06026631 - Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study. N/A
Completed NCT03850990 - Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss N/A
Not yet recruiting NCT03601273 - Bariatric Embolization Trial for the Obese Nonsurgical Phase 1
Completed NCT02899559 - Messages and Plans to Increase Gym Utilization N/A
Active, not recruiting NCT02557022 - Meta Analysis of the Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight N/A
Completed NCT02158130 - Effects of Aerobic Exercise Detraining N/A
Completed NCT02188251 - A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants Phase 2
Completed NCT02402985 - Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics N/A
Completed NCT01665339 - Preload, Weight Management, Risk of Cardiovascular Disease Phase 3
Completed NCT01131871 - Innovative Approaches to Diet, Exercise and Activity Phase 2
Completed NCT01170390 - Oral Contraceptives and Body Mass Index Phase 4
Completed NCT02395835 - Methylation of the PPARg Promoter Region in Pregnancy N/A
Completed NCT00814554 - Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers N/A
Completed NCT04901949 - The Course of Acute Pancreatitis in Patients With Different BMI Groups
Active, not recruiting NCT03843424 - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers N/A
Active, not recruiting NCT03575897 - Serial Assessment of Body Fat Accrual in Very Preterm Infants N/A
Active, not recruiting NCT05601804 - TARGETing Healthy Weight Loss in the Context of Food Insecurity
Not yet recruiting NCT05004558 - Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias N/A